|Blazer Ventures||New York, New York, United States|
|Cortland Credit||Canada, Ontario, Toronto|
|DH Private Equity Partners||England, London, United Kingdom|
|Differential Ventures||New York, New York, United States|
|Fort Point Angels||Boston, Massachusetts, United States|
|Founder of Avast||-|
|Giant Ventures||England, London, United Kingdom|
|Guild Capital||Florida, Miami, United States|
|Heise Medien||Germany, Hanover, Niedersachsen|
|Huabin Venture Capital||China, Shanghai|
|IPPO||Japan, Kanagawa Prefecture, Kawasaki|
|Latin Idea Ventures||Distrito Federal, Mexico, Mexico City|
|Revolution Ventures||District of Columbia, United States, Washington|
|Samkee Automotive||Gyeonggi-do, Kyonggi-do, South Korea|
|SFR Development||France, Ile-de-France, Paris|
|Shenzhen Qucheng Investment Holding Co.||-|
|Sporos Bioventures||Houston, Texas, United States|
|Telescope||California, Los Angeles, United States|
|Three Leaf Ventures||Colorado, Denver, United States|
|$14M||06 Jul 2022||Israel, North District, Israel|
|$1M||26 Jan 2022||Misgav, HaZafon, Israel|
|$16M||01 Nov 2021||Misgav, HaZafon, Israel|
|$2M||11 Oct 2021||Misgav Regional Council, North District, Israel|
|$3M||04 Oct 2021||Misgav, HaZafon, Israel|
|$7M||04 Aug 2021||Misgav Regional Council, North District, Israel|
|21 Jun 2021||Ness Ziona, HaMerkaz, Israel|
|$4M||09 Jun 2021||Misgav Regional Council, North District, Israel|
|$2M||09 Mar 2021||Israel, North District|
– Vensica closed an investment round of $16m.
– The round was led by Israel Biotech Fund (“IBF”), a venture fund investing in Israeli and Israeli-related biotechnology and pharmaceutical companies.
– Other investors in the round include Laborie, a global urology device company, Lew Pell, an experienced medical device investor, Agriline, a trust of which Vincent Tchenguiz is a discretionary beneficiary, and The Trendlines Group, an investor in innovation-based medical and agricultural technologies.
– Funds raised will support the company’s phase II multicenter clinical trials in Europe and the USA.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.